OurCrowd

OurCrowd, established in 2013, is a global venture investing platform headquartered in Israel. It specializes in connecting accredited investors with curated, high-quality early-stage companies across various sectors, including healthcare, technology, energy, and transportation. OurCrowd invests in and supports its portfolio companies throughout their lifecycle, providing mentorship, industry connections, and follow-on funding opportunities. It is the most active venture investor in Israel and has a strong presence in the United States and other global markets.

Denes Ban

Managing Partner

Dan Bennett

Managing Partner

Dean Berger

Associate

Morry Blumenfeld

Venture Partner

Guy Dassa

Senior Associate

Past deals in Image Recognition

Hailo Technologies

Series C in 2024
Hailo Technologies is an AI chipmaker that develops edge-level processors for running deep learning tasks locally on devices. Its processors, designed with patented silicon architecture, deliver data center-class AI performance on edge devices with low power, small size, and low cost. The company provides end-to-end solutions including software and development tools to enable real-time deep learning applications such as object detection and image enhancement without cloud processing. Its technology targets a range of markets including automotive, security, drones, industrial automation, smart home devices, and portable computers. Founded in 2017 and headquartered in Tel Aviv, Hailo aims to empower devices to analyze data and make decisions locally, advancing edge AI applications.

DataLoop

Series B in 2022
Founded in 2017, DataLoop specializes in developing artificial intelligence products for data automation. It provides visual recognition solutions and data annotation services, streamlining the process of preparing visual data for machine learning.

InZiv

Series A in 2022
Founded in 2018, InZiv specializes in developing advanced inspection tools for flat panel displays. Its flagship product, InZiv FPD, employs proprietary nano-scale optics and near-field microscopy to ensure quality assurance in display panels such as OLEDs, MicroLEDs, and QLEDs.

Scopio Labs

Series C in 2022
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.

Hailo Technologies

Series C in 2021
Hailo Technologies is an AI chipmaker that develops edge-level processors for running deep learning tasks locally on devices. Its processors, designed with patented silicon architecture, deliver data center-class AI performance on edge devices with low power, small size, and low cost. The company provides end-to-end solutions including software and development tools to enable real-time deep learning applications such as object detection and image enhancement without cloud processing. Its technology targets a range of markets including automotive, security, drones, industrial automation, smart home devices, and portable computers. Founded in 2017 and headquartered in Tel Aviv, Hailo aims to empower devices to analyze data and make decisions locally, advancing edge AI applications.

SeeTrue

Series A in 2021
Founded in 2018, SeeTrue is an AI-based platform that optimizes security screening processes. It uses Artificial Intelligence for automatic threat detection and alarm resolution on X-ray and CT systems, enhancing passenger throughputs, experience, security, and reducing labor costs.

RideVision

Series A in 2020
RideVision is a technology company focused on enhancing motorcycle safety through its innovative Collision Aversion Technology (CAT™). This system utilizes computer vision and neural networks to detect, predict, and alert riders to potential road threats. By leveraging standard hardware and cameras, RideVision's technology delivers warning signals within milliseconds, significantly improving the safety and riding experience for motorcyclists. The system is designed to be compatible with a wide range of motorcycles, whether new or used, making advanced safety features accessible to a diverse audience of riders.

DataLoop

Series A in 2020
Founded in 2017, DataLoop specializes in developing artificial intelligence products for data automation. It provides visual recognition solutions and data annotation services, streamlining the process of preparing visual data for machine learning.

Sight Diagnostics

Series D in 2020
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.

Scopio Labs

Series B in 2020
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.

Hailo Technologies

Series B in 2020
Hailo Technologies is an AI chipmaker that develops edge-level processors for running deep learning tasks locally on devices. Its processors, designed with patented silicon architecture, deliver data center-class AI performance on edge devices with low power, small size, and low cost. The company provides end-to-end solutions including software and development tools to enable real-time deep learning applications such as object detection and image enhancement without cloud processing. Its technology targets a range of markets including automotive, security, drones, industrial automation, smart home devices, and portable computers. Founded in 2017 and headquartered in Tel Aviv, Hailo aims to empower devices to analyze data and make decisions locally, advancing edge AI applications.

Autobrains

Series B in 2019
Autobrains develops a visual intelligence platform for safer autonomous driving. Its technology, backed by over 200 patents, uses signature-based representation structures and unsupervised learning to understand vehicle environments comprehensively.

Juganu

Venture Round in 2019
Juganu Ltd. is a technology company based in Rosh Haayin, Israel, founded in 2011. It specializes in developing a platform that transforms existing LED lighting infrastructure into a comprehensive wireless network, enabling a variety of applications for smart cities and smart retail environments. The company's solutions address key urban challenges through features such as face and license plate recognition, parking management, suspect tracking, and hazard detection. By integrating artificial intelligence and edge computing, Juganu's platform provides real-time data analysis while ensuring privacy protection. This innovative approach facilitates the digitization of public spaces and enhances connectivity, offering clients significant cost and time savings in deployment.

MultiVu Technologies

Seed Round in 2019
MultiVu Technologies develops 3D imaging solutions centered on a single-lens camera for face authentication. Based in Tel Aviv, Israel, the company combines face and depth recognition using a compact sensor and deep learning algorithms to secure biometric data. Its light field technology enables rapid 3D snapshots in broad daylight without additional hardware, delivering eye safety, power efficiency, and cost advantages relative to leading brands. The solution is designed for use on mobile and stationary devices, offering biometric authentication that enhances security while maintaining user convenience. By integrating depth information with facial features, the technology aims to improve accuracy and resistance to spoofing, facilitating safer access control and identity verification across diverse applications.

Brodmann17

Series A in 2019
Brodmann17 develops computer-vision driven AI for mobility safety, including pedestrian and face detection, with software that runs on edge devices and in the cloud. Founded in 2016 and headquartered in Hod Hasharon, Israel, the company uses deep learning to extract information from video to enhance automated driving systems while optimally balancing performance, hardware constraints, and cost. Its patented perception software is hardware-agnostic and easy to deploy across processors, enabling significant reductions in compute requirements and expanding access to smart mobility across automotive, telematics, and micro-mobility applications. The company targets scalable, deployable vision AI for real-world environments and has attracted global backing from technology investors and strategic partners in Silicon Valley, Europe, and Israel.

Sight Diagnostics

Series C in 2019
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.

Hailo Technologies

Series A in 2019
Hailo Technologies is an AI chipmaker that develops edge-level processors for running deep learning tasks locally on devices. Its processors, designed with patented silicon architecture, deliver data center-class AI performance on edge devices with low power, small size, and low cost. The company provides end-to-end solutions including software and development tools to enable real-time deep learning applications such as object detection and image enhancement without cloud processing. Its technology targets a range of markets including automotive, security, drones, industrial automation, smart home devices, and portable computers. Founded in 2017 and headquartered in Tel Aviv, Hailo aims to empower devices to analyze data and make decisions locally, advancing edge AI applications.

VAYAVISION

Seed Round in 2018
VayaVision Sensing Ltd. is a technology company that specializes in developing perception engine software aimed at enhancing the safety and efficiency of autonomous driving. Founded in 2016 and headquartered in Or Yehuda, Israel, the company offers VAYA-Drive, an artificial intelligence cognition platform that integrates raw data fusion with advanced computer vision techniques. This platform generates comprehensive environmental models, enabling critical functions such as road and free space detection, lane detection, object detection and tracking, and recognition of traffic signs. By utilizing deep learning algorithms, VayaVision delivers a reliable detection and classification system that accurately assesses the size, shape, and velocity of surrounding objects, including small obstacles. This innovative approach not only improves sensing capabilities for autonomous vehicles but also contributes to cost reductions within the automotive industry. Since July 2020, VayaVision has operated as a subsidiary of LeddarTech Inc.

Zebra Medical Vision

Venture Round in 2018
Zebra Medical Vision is an Israel-based company that develops an imaging analytics platform for healthcare. The platform supplies clinicians with imaging research tools, provides advanced learning and computer-vision diagnostic algorithms for developers, and offers risk management and preventative care tools for providers. The company also offers researchers access to tools and datasets to accelerate the development of decision-support and diagnostic technologies. Founded in 2014 and headquartered in Shefayim, Zebra Medical Vision collaborates with partners such as USARAD Holdings and TELUS Ventures and has deployed its AI-enabled imaging analytics across hospitals worldwide.

Zebra Medical Vision

Series C in 2018
Zebra Medical Vision is an Israel-based company that develops an imaging analytics platform for healthcare. The platform supplies clinicians with imaging research tools, provides advanced learning and computer-vision diagnostic algorithms for developers, and offers risk management and preventative care tools for providers. The company also offers researchers access to tools and datasets to accelerate the development of decision-support and diagnostic technologies. Founded in 2014 and headquartered in Shefayim, Zebra Medical Vision collaborates with partners such as USARAD Holdings and TELUS Ventures and has deployed its AI-enabled imaging analytics across hospitals worldwide.

Hailo Technologies

Series A in 2018
Hailo Technologies is an AI chipmaker that develops edge-level processors for running deep learning tasks locally on devices. Its processors, designed with patented silicon architecture, deliver data center-class AI performance on edge devices with low power, small size, and low cost. The company provides end-to-end solutions including software and development tools to enable real-time deep learning applications such as object detection and image enhancement without cloud processing. Its technology targets a range of markets including automotive, security, drones, industrial automation, smart home devices, and portable computers. Founded in 2017 and headquartered in Tel Aviv, Hailo aims to empower devices to analyze data and make decisions locally, advancing edge AI applications.

Innoviz Technologies

Series B in 2017
Innoviz Technologies designs and manufactures solid-state LiDAR sensors and develops perception software to facilitate mass-production of autonomous vehicles. Its products include InnovizPro for various applications and InnovizOne for Level 3-5 autonomous driving. The company offers object identification, sensor fusion, mapping, and localization solutions. Backed by strategic partners and investors such as Magna International, Samsung, Aptiv, and others, Innoviz Technologies is headquartered in Rosh HaAyin, Israel.

Scopio Labs

Venture Round in 2017
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.

Sight Diagnostics

Series B in 2016
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.

Zebra Medical Vision

Series B in 2016
Zebra Medical Vision is an Israel-based company that develops an imaging analytics platform for healthcare. The platform supplies clinicians with imaging research tools, provides advanced learning and computer-vision diagnostic algorithms for developers, and offers risk management and preventative care tools for providers. The company also offers researchers access to tools and datasets to accelerate the development of decision-support and diagnostic technologies. Founded in 2014 and headquartered in Shefayim, Zebra Medical Vision collaborates with partners such as USARAD Holdings and TELUS Ventures and has deployed its AI-enabled imaging analytics across hospitals worldwide.

Zebra Medical Vision

Series A in 2015
Zebra Medical Vision is an Israel-based company that develops an imaging analytics platform for healthcare. The platform supplies clinicians with imaging research tools, provides advanced learning and computer-vision diagnostic algorithms for developers, and offers risk management and preventative care tools for providers. The company also offers researchers access to tools and datasets to accelerate the development of decision-support and diagnostic technologies. Founded in 2014 and headquartered in Shefayim, Zebra Medical Vision collaborates with partners such as USARAD Holdings and TELUS Ventures and has deployed its AI-enabled imaging analytics across hospitals worldwide.

Zebra Medical Vision

Seed Round in 2015
Zebra Medical Vision is an Israel-based company that develops an imaging analytics platform for healthcare. The platform supplies clinicians with imaging research tools, provides advanced learning and computer-vision diagnostic algorithms for developers, and offers risk management and preventative care tools for providers. The company also offers researchers access to tools and datasets to accelerate the development of decision-support and diagnostic technologies. Founded in 2014 and headquartered in Shefayim, Zebra Medical Vision collaborates with partners such as USARAD Holdings and TELUS Ventures and has deployed its AI-enabled imaging analytics across hospitals worldwide.

Sight Diagnostics

Series A in 2014
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.

Sight Diagnostics

Seed Round in 2011
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.